968 related articles for article (PubMed ID: 15661132)
1. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
2. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India.
Rahete NP; Zodpey SP; Kamble KM
Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India.
Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of childhood pulmonary tuberculosis: a case control study in Nagpur, India.
Zodpey SP; Shrikhande SN; Maldhure BR; Vasudeo ND; Kulkarni SW
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):285-8. PubMed ID: 9886114
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis.
Zodpey SP; Maldhure BR; Kulkarni SW
J Commun Dis; 2004 Sep; 36(3):159-65. PubMed ID: 16509251
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Bacillus Calmette Guerin (BCG) against leprosy: a population-based case-control study in Nagpur, India.
Zodpey SP; Bansod BS; Shrikhande SN; Maldhure BR; Kulkarni SW
Lepr Rev; 1999 Sep; 70(3):287-94. PubMed ID: 10603718
[TBL] [Abstract][Full Text] [Related]
9. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
Zodpey SP
Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of bacillus Calmette Guerin (BCG) vaccination against extra-pulmonary tuberculosis: a case-control study.
Zodpey SP; Maldhure BR; Dehankar AG; Shrikhande SN
J Commun Dis; 1996 Jun; 28(2):77-84. PubMed ID: 8810141
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of bacillus of Calmette-Guerin (BCG) vaccination against tuberculous meningitis: a case-control study.
Zodpey SP; Maldhure BR; Shrikhande SN; Tiwari RR
J Indian Med Assoc; 1996 Sep; 94(9):338-40. PubMed ID: 9019079
[TBL] [Abstract][Full Text] [Related]
12. Association between leprosy and HIV infection in Tanzania.
van den Broek J; Chum HJ; Swai R; O'Brien RJ
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):203-10. PubMed ID: 9251592
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Bacillus Calamette Guerin (BCG) vaccination against genital tuberculosis: a case-control study.
Zodpey SP; Shrikhande SN; Maldhure BR; Kulkarni SW
J Commun Dis; 1997 Dec; 29(4):345-9. PubMed ID: 10085640
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of Bacillus Calmette-Guerin (BCG) vaccination in children with extra-pulmonary tuberculosis, but not the pulmonary disease. A case-control study in Rosario, Argentina.
Bonifachich E; Chort M; Astigarraga A; Diaz N; Brunet B; Pezzotto SM; Bottasso O
Vaccine; 2006 Apr; 24(15):2894-9. PubMed ID: 16434130
[TBL] [Abstract][Full Text] [Related]
16. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
17. BCG vaccination protects against leprosy in Venezuela: a case-control study.
Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
[TBL] [Abstract][Full Text] [Related]
18. The distribution and implications of BCG scars in northern Malawi.
Fine PE; Ponnighaus JM; Maine N
Bull World Health Organ; 1989; 67(1):35-42. PubMed ID: 2706726
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil.
Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274
[TBL] [Abstract][Full Text] [Related]
20. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
